Company / Working Capital per Share
Aligos Therapeutics, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.77
FY2025
5-year range
$0.77 / $13.45
FY2021-FY2025
Trend
-94.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2.73 to $0.77 over the past 2 years.
Based on SEC 10-K filings.
0.77 in FY2025 with a 5-year CAGR of -57.5%.
Declined from $2.73 to $0.77 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -31.0%
- 5-Year CAGR
- -57.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 94.3% year-over-year.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.77 | -94.3% |
| FY2024 | $13.45 | +392.7% |
| FY2023 | $2.73 | +16.1% |
| FY2022 | $2.35 | -45.8% |
| FY2021 | $4.34 | -92.2% |
| FY2020 | $55.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026